Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes
Alessandra Gambineri(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Renato Pasquali(University of Bologna), Paola Altieri(University of Genoa), Lamberto Manzoli, Laura Patton(University of Bologna), Uberto Pagotto(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Carmine Pizzi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 225
Related Papers
Heart Rate Variability Today
|Progress in Cardiovascular Diseases|2012|457
An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence
|Hormone Research in Paediatrics|2017|451
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
|Diabetes Care|2019|442
Endothelial Function Predicts Future Development of Coronary Artery Disease
|Circulation|2004|348
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
|Journal of Endocrinological Investigation|2019|292